INNOVENT BIO (01801.HK)'s total product revenue for 2024 amounted to more than RMB8.2 billion, representing a robust YoY ...

The stock is trading at 1.0150, up 0.6573, gaining 183.7573% on volume of over 422 Million shares, with a day's high of $1.11. The stock announced breaking news on its Monoclonal Antibody designed to ...

The list of 36 drugs, which are exempt from basic customs duty, includes many expensive and imported medicines that can ...

Six other drugs will have a concessional customs duty of 5% as part of efforts to increase accessibility of expensive advanced medicines for a larger section of patients ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

Currently, there are ten approved indications for toripalimab in the Chinese mainland: The ten indications have been included in the National Reimbursement Drug List (NRDL) (2024 Edition). Toripalimab ...

Currently, there are ten approved indications for toripalimab in the Chinese mainland: The 10 indications have been included in the National Reimbursement Drug List (NRDL) (2024 Edition). Toripalimab ...

monoclonal antibodies and viral vaccines. "Over 80% of biologic drugs and 90% of vaccines require temperature-controlled conditions. This approach could revolutionize their storage and ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...

It is a fully human monoclonal ... antibody’s long half-life optimization and outstanding biophysical properties provide a favourable dosing advantage. Prior to the execution of the license agreement, ...

The FDA’s approval of Amgen’s DLL3 × CD3 bispecific antibody tarlatamab (Imdelltra) last year validated the DLL3 cancer target, demonstrating its approvability in extensive-stage small-cell ...

MIT’s new AI model predicts antibody structures with greater accuracy, aiding disease treatment and streamlining drug discovery. With this model, researchers may be able to discover antibody drugs ...